Subscribe to
this category


A total of 54 posts are filed under Finance
Amicus Therapeutics to Acquire Celenex, Scoring Gene Therapy Portfolio for Neurologic Disorders
Rare Daily Staff Amicus Therapeutics agreed to acquire Celenex in a deal that provides it worldwide development and commercial rights for… Continue Reading
Bill Would Seek to Bridge Development Gap for Rare Disease Drugs with Megafund
Rare Daily Staff A federal bill intended to address what its authors call the “ever-widening funding gap” between basic research and… Continue Reading
Fulcrum Therapeutics Completes $80 Million Financing to Advance Rare Disease Pipeline
Rare Daily Staff Fulcrum Therapeutics said it completed an $80 million financing, which will be used to advance into clinical testing the… Continue Reading
Evox Therapeutics completes $45.4 Million Financing of Exosome Platform
Rare Daily Staff Evox Therapeutics, which is developing a platform to allow drugs to be delivered across the blood-brain barrier and to… Continue Reading
RDMD Raises $3 Million in Seed Funding for Patient-Data Platform to Accelerate Rare Disease Drug Development
Rare Daily Staff RDMD said it has completed a $3 million seed financing to advance its rare disease patient-data platform to accelerate drug… Continue Reading
Orchard Therapeutics Raises $150 Million to Advance Gene Therapy Pipeline
Rare Daily Staff Orchard Therapeutics said it completed an oversubscribed series C financing of $150 million to advance its gene therapy… Continue Reading
Therachon Raises $60 Million to Advance Achondroplasia Drug and Expand Pipeline
Rare Daily Staff Therachon said it has completed a $60 million financing that will be used to advance its experimental therapy in… Continue Reading
1 2 3 8

Follow us on Twitter